Delivery Order SPE2DB22D1106-SPE2DB25FFFN2
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,136.12 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Journavx 50 mg tablets (30-count packaging). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $4,491.46. This non-set-aside award represents a competitive delivery order for pharmaceutical supplies supporting federal medical procurement needs. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $117,115.05 to AmerisourceBergen Drug Corp on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive delivery order, issued under contract number 4569060720, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a $17,849.85 delivery order to AmerisourceBergen Drug Corp for OJJAARA 200 mg tablets in 30-count units, with a completion date of September 2, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for OJJAARA 100 mg tablets in quantities of 30, with a contract ceiling value of $17,912.32. This firm fixed-price delivery order, set to be completed by August 14, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $33,521.05 to AmerisourceBergen Drug Corp on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $527,598.14 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,586.87 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,916.19 to AmerisourceBergen Drug Corp on August 14, 2025, for pharmaceutical products and medical supplies. This firm fixed-price delivery order, issued under a non-competitive, non-set-aside procurement, is scheduled for completion by August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $134,126 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFFN2Delivery Order
The Defense Logistics Agency awarded a $2,111.64 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Journavx 50 mg tablets (100-count unit dose packaging). This firm fixed-price contract, which is not set-aside and is competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and healthcare system procurement. The company's SPE2DX contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies globally to support Defense Health Agency and other government healthcare systems across multiple therapeutic domains. This specific delivery order represents a routine pharmaceutical fulfillment under that overarching prime vendor vehicle, consistent with the company's demonstrated capability to meet federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/27/25 |